Ranbaxy gets nod to market Ran-Simvastatin tabs in Canada

Ranbaxy Laboratories Limited (RLL) has received final approval in Canada to manufacture and market Ran-Simvastatin 5 mg, 10 mg, 20 mg, 40 mg and 80 mg tablets (simvastatin) from Health Canada, Therapeutic Products Directorate (TPD). 

Total generic market size of simvastatin tablets in Canada is $153 million ($CAD) [IMS-CDH: October 2008]. Ran-Simvastatin tablets are indicated for use as a lipid metabolism regulator.


Popular posts from this blog

GOP Senator says it's hard to fund $14 billion children's health care program — then advocates for $1 trillion tax cut

Trump wants more mental health care; Alabama says it's trying